|Bid||0.0000 x N/A|
|Ask||0.0000 x N/A|
|Day's range||1.6500 - 1.7300|
|52-week range||1.6500 - 1.7300|
|Beta (5Y monthly)||1.94|
|PE ratio (TTM)||N/A|
|Earnings date||21 Mar 2022 - 25 Mar 2022|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
Even the best investor on earth makes unsuccessful investments. But it would be foolish to simply accept every...
At this time, I would like to turn the conference over to Amy Conrad from investor relations. Leading the call today is Dr. Erik Holmlin, CEO of Bionano. After market closed today, Bionano issued a press release announcing its financial results for the first quarter of 2022.
Bionano Genomics, Inc. (BNGO) delivered earnings and revenue surprises of -37.50% and 5.48%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?